» Articles » PMID: 8232248

Molecular and Biochemical Features of Poly (ADP-ribose) Metabolism

Overview
Publisher Springer
Specialty Biochemistry
Date 1993 May 26
PMID 8232248
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

In the past five years, poly(ADP-ribosyl)ation has developed greatly with the help of molecular biology and the improvement of biochemical techniques. In this article, we describe the physico-chemical properties of the enzymes responsible for the synthesis and degradation of poly(ADP-ribose), respectively poly(ADP-ribose) polymerase and poly(ADP-ribose) glycohydrolase. We then discuss the possible roles of this polymer in DNA repair and replication as well as in cellular differentiation and transformation. Finally, we put forward various hypotheses in order to better define the function of this polymer found only in eucaryotes.

Citing Articles

Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions.

Medrano M, Contreras M, Caballero-Velazquez T, Martinez L, Bejarano-Garcia J, Calderon-Ruiz R Br J Cancer. 2024; 130(9):1529-1541.

PMID: 38461169 PMC: 11058274. DOI: 10.1038/s41416-024-02618-6.


PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities.

Li W, Wang F, Song G, Yu Q, Du R, Xu P Front Pharmacol. 2023; 14:1198948.

PMID: 37351512 PMC: 10283042. DOI: 10.3389/fphar.2023.1198948.


PARP-1 Is a Potential Marker of Retinal Photooxidation and a Key Signal Regulator in Retinal Light Injury.

Li X, Zhang Z, Fan B, Li Y, Song D, Li G Oxid Med Cell Longev. 2022; 2022:6881322.

PMID: 36124087 PMC: 9482536. DOI: 10.1155/2022/6881322.


Opinion: PARP inhibitors in cancer-what do we still need to know?.

Wicks A, Krastev D, Pettitt S, Tutt A, Lord C Open Biol. 2022; 12(7):220118.

PMID: 35892198 PMC: 9326299. DOI: 10.1098/rsob.220118.


Emerging role of PARP-1 and PARthanatos in ischemic stroke.

Liu S, Luo W, Wang Y J Neurochem. 2021; 160(1):74-87.

PMID: 34241907 PMC: 9010225. DOI: 10.1111/jnc.15464.


References
1.
Hunting D, Gowans B, HENDERSON J . Specificity of inhibitors of poly(ADP-ribose) synthesis. Effects on nucleotide metabolism in cultured cells. Mol Pharmacol. 1985; 28(2):200-6. View

2.
Cohen J, Catino D, Petzold S, Berger N . Activation of poly(adenosine diphosphate ribose) polymerase by SV 40 minichromosomes: effects of deoxyribonucleic acid damage and histone H1. Biochemistry. 1982; 21(20):4931-40. DOI: 10.1021/bi00263a016. View

3.
Scovassi A, Izzo R, Franchi E, Bertazzoni U . Structural analysis of poly(ADP-ribose)polymerase in higher and lower eukaryotes. Eur J Biochem. 1986; 159(1):77-84. DOI: 10.1111/j.1432-1033.1986.tb09835.x. View

4.
Herzog H, Zabel B, Schneider R, Auer B, Hirsch-Kauffmann M, Schweiger M . Human nuclear NAD+ ADP-ribosyltransferase: localization of the gene on chromosome 1q41-q42 and expression of an active human enzyme in Escherichia coli. Proc Natl Acad Sci U S A. 1989; 86(10):3514-8. PMC: 287168. DOI: 10.1073/pnas.86.10.3514. View

5.
Borek C, Morgan W, Ong A, Cleaver J . Inhibition of malignant transformation in vitro by inhibitors of poly(ADP-ribose) synthesis. Proc Natl Acad Sci U S A. 1984; 81(1):243-7. PMC: 344648. DOI: 10.1073/pnas.81.1.243. View